Completed PHASE3 INTERVENTIONAL 6-arm NCT00438399

Subject Preference for Scalp Psoriasis Treatment

Subject Preference Comparison Between Clobetasol Propionate Shampoo, 0.05% and Three Other Topical Corticosteroids in the Treatment of Moderate to Severe Scalp Psoriasis

Sponsor: Galderma R&D

Conditions Scalp Psoriasis

Interventions C. propionate - Corticosteroid 1 C. propionate -Corticosteroid 3 C. propionate- Corticosteroid 2 Corticosteroid 1- C. propionate Corticosteroid 2 - C. propionate Corticosteroid 3 - C. propionate

Updated 6 times since 2017 Last updated: Feb 16, 2021 Started: Feb 28, 2007 Primary completion: Jan 31, 2008 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Scalp Psoriasis and is currently completed. Galderma R&D leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Mar 2021 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Galderma R&D

Data source: Galderma R&D

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Modena, Italy